TLR4 and metabolic dysfunction-associated steatohepatitis: Studies suggested a critical role of LPS/TLR-4 signaling axis in the inflammatory pathways associated with NASH36, and the Inhibition of LPS-TLR4 signaling with antibiotics attenuated liver fibrosis development in rat NASH model36.